Providers/Grant Support
This activity is jointly provided by Global Education Group and Opt-in CME LLC.
This activity is supported in part by an independent education grant from ImmunityBio.
Credits Available
- Physicians — maximum of 0.5 AMA PRA Category 1 Credits™
All other healthcare professionals completing this course will be issued a certificate of participation.
Target Audience
The educational design of this activity addresses the needs of Practicing Physicians and Urologists, Oncologists, Healthcare Professionals in Multidisciplinary Teams involved in the treatment of patients with bladder cancer.
Program Overview
Bladder cancer remains a prevalent and significant healthcare challenge, with non–muscle-invasive bladder cancer (NMIBC) constituting a substantial portion of cases. Among these, carcinoma in situ (CIS) represents a high-risk entity characterized by a heightened probability of recurrence, progression, and mortality. Given the aggressive nature of NMIBC, it is imperative that healthcare providers (HCPs) stay informed about the latest advancements in diagnostic modalities and treatment options. This continuing medical education (CME) activity aims to equip HCPs with the latest knowledge and clinical insights on diagnosing high-grade CIS. The program will also provide participants with a comprehensive understanding of CIS management, equipping them with the knowledge needed to optimize patient outcomes through evidence-based, patient-centric approaches.
Learning Objectives
- Upon completion of this activity, participants should be better able to:
- Discuss how to diagnose high-grade CIS by differentiating lesions from normal tissue.
- Utilize assistive technologies to enhance CIS detection.
- Explain how to apply current guidelines to perform prostate cancer biopsies in patients with high-risk tumors and positive cytology.
- Identify promising standard-of-care alternatives with improved survival and reduced side effects that maintain quality of life.
- Describe how to incorporate immunotherapy options based on the latest clinical evidence.
Faculty
Joshua J. Meeks, MD, PhD
Associate Professor of Urology, Biochemistry and Molecular Genetics,
Northwestern University, Feinberg School of Medicine
Chicago, IL
Sandip M. Prasad, MD, MPhil
Vice-Chair and Surgical Director of Genitourinary Oncology,
Morristown Medical Center/Atlantic Health System
Clinical Associate Professor,
Rutgers New Jersey Medical School;
Clinical Assistant Professor,
Thomas Jefferson University
Philadelphia, PA
Accreditation Statement
This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of Global Education Group (Global) and Opt-In CME. Global is accredited by the ACCME to provide continuing medical education for physicians.
Credit Designation
Global Education Group designates this enduring activity for a maximum of 0.5 AMA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the enduring activity.
Disclosures of Conflicts of Interest
Global Education Group (Global) adheres to the policies and guidelines, including the Standards for Integrity and Independence in Accredited CE, set forth to providers by the Accreditation Council for Continuing Medical Education (ACCME) and all other professional organizations, as applicable, stating those activities where continuing education credits are awarded must be balanced, independent, objective, and scientifically rigorous. All persons in a position to control the content of an accredited continuing education program provided by Global are required to disclose all financial relationships with any ineligible company within the past 24 months to Global. All financial relationships reported are identified as relevant and mitigated by Global in accordance with the Standards for Integrity and Independence in Accredited CE in advance of delivery of the activity to learners. The content of this activity was vetted by Global to assure objectivity and that the activity is free of commercial bias.
All relevant financial relationships have been mitigated.
The faculty have the following relevant financial relationships with ineligible companies:
The planners and managers at Global Education Group have no relevant financial relationships to disclose.
The planners and managers at Opt-In CME, LCC have no relevant financial relationships to disclose.
Instructions For Participation and Credit
There are no fees for participating and receiving CME credit for this enduring activity. To receive CME credit participants must:
- Read the CME/CE information and faculty disclosures.
- Participate in the online activity.
- Submit the evaluation form.
Certificates will be available for the participant to download.
Course Viewing Requirements
Supported Browsers:
Desktop: Newest and last prior version of Google Chrome, Firefox, Safari, and Microsoft Edge
Mobile devices: Newest and last prior version of Safari and Google Chrome
Supported Phones & Tablets:
All devices
Disclosure of Unlabeled Use
This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. Global Education Group (Global) and Opt-In CME do not recommend the use of any agent outside of the labeled indications.
The opinions expressed in the educational activity are those of the faculty and do not necessarily represent the views of any organization associated with this activity. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.
Disclaimer
This activity is designed for educational purposes. Participants have a responsibility to utilize this information to enhance their professional development to improve patient outcomes. Conclusions drawn by the participants should be derived from careful consideration of all available scientific information. The participant should use his/her clinical judgment, knowledge, experience, and diagnostic decision-making before applying any information, whether provided here or by others, for any professional use.
Contact Information
For CME questions please contact: [email protected].